Signal active
Investment Firm
Overview
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine.
Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.
Highlights
2000
Financial Services
11-50
113
40
25
Early Stage Venture, Late Stage Venture, Seed, Private Equity
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Hatteras Venture Partners, established in 2000 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Enterprise Software, Information Technology, Software, Computer, Financial Services, Venture Capital, SaaS, Health Care, Medical Device, Finance. The organization boasts a portfolio of 113 investments, with an average round size of $25.8M and 25 successful exits. Their recent investments include ArtusLabs, Southern Capitol Ventures, SpineAlign Medical, Intersouth Partners, Novartis Venture Fund. The highest investment round they participated in was $227.6B. Among their most notable exits are ArtusLabs and Southern Capitol Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
113
28
40
25
Investments
113
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jun 20, 2023 | Veralox Therapeutics | Biotechnology | 24.0M |
Apr 22, 2024 | iVEAcare | Health Care | 27.5M |
Apr 24, 2024 | - | - | 28.0M |
Jun 25, 2024 | Endogenex | Health Care | 88.0M |
Exits
25
Funding Timeline
113
0
5
Funding Rounds
113
Hatteras Venture Partners has raised 113 rounds. Their latest funding was raised on Jun 25, 2024 from a Series C - Endogenex round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jun 20, 2023 | Venture Round - Veralox Therapeutics | - | 24.0M | - |
Apr 22, 2024 | Series A - iVEAcare | - | 27.5M | - |
Apr 24, 2024 | Series C - AtaCor Medical | - | 28.0M | - |
Jun 25, 2024 | Series C - Endogenex | - | 88.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.